UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q/A

(Amendment Number 2)

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended March 31, 2011

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _____ to _____.

Commission File No. 333-132056

HUIHENG MEDICAL, INC.

(Exact Name of Registrant as Specified in Its Charter)

Nevada		20-4078899
(State or Other Jurisdiction Of Incorporation or Organization)		(I.R.S. Employer Identification Number)

Huiheng Building, Gaoxin 7 Street South,
Keyuannan Road, Nanshan District,
Shenzhen Guangdong, P.R. China 518057		N/A
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s telephone number, including area code 86-755-25331366

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.

Yes x No o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes ¨ No ¨

Indicate by checkmark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-3 of the Exchange Act.

Large accelerated filer	¨	Accelerated filer	¨

Non-accelerated filer	¨	Smaller reporting company	x
(Do not check if a smaller reporting company)

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes ¨ No x

As of May 1, 2011, there were 14,030,637 shares of the issuer’s $0.001 par value common stock outstanding.

Explanatory Note. The Company is filing this amendment number 2 to Form 10-Q for the quarterly period ended March 31, 2011 to file as exhibits revised English translations of agreements related to Tibet Changdu Huiheng Development Ltd.’s acquisition from its major customer, Shenzhen Jiancheng Investment Ltd., medical accelerator systems and the operating rights at four medical centers.

Item 6. Exhibits

Exhibit No		Description

10.8		Transfer Agreement – Sheng’an Hospital in Lianyungang

10.9		Transfer Agreement – Dali 60 Hospital

10.10		Transfer Agreement – Huici Hospital in Heze

10.11		Transfer Agreement – Liaocheng Hospital

31.1		Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2		Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

___________________________

- 2 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	HUIHENG MEDICAL, INC.


Date: October 13, 2011	By:	/s/ Hui Xiaobing
		Hui Xiaobing
		Chief Executive Officer
		(Principal Executive Officer)


Date: October 13, 2011	By:	/s/ Richard Shen
		Richard Shen
		Chief Financial Officer
		(Principal Accounting and Financial Officer)

- 3 -

HUIHENG MEDICAL, INC. 10-Q/A